ClaudiaLOrdonezMD
Pediatric Pulmonology • Boston, MAPediatric Asthma Pulmonology
Clinical Instructor in Pediatrics, Boston Children's Hospital
Are you Dr. Ordonez?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-1900Fax+1 617-730-0084
Summary
- Dr. Claudia Ordonez, MD is a pediatric pulmonologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Boston Children's Hospital and is a Clinical Instructor in Pediatrics at Boston Children's Hospital.
Education & Training
University of California (San Francisco)Fellowship, Pediatric Pulmonology, 1995 - 1998
Children's Hospital-OaklandResidency, Pediatrics, 1991 - 1994- University of California San Francisco School of MedicineClass of 1991
Certifications & Licensure
MA State Medical License 1998 - 2024
Publications & Presentations
PubMed
- 1551 citationsA CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W. Ramsey, Jane C. Davies, N. Gerard McElvaney, Elizabeth Tullis, Scott C. Bell
The New England Journal of Medicine. 2011-11-03 - 823 citationsA virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatusJoseph D. Mougous, Marianne E. Cuff, Stefan Raunser, Aimee Shen, M. Zhou
Science. 2006-06-09 - 576 citationsEffect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR MutationFrank J. Accurso, Steven M. Rowe, John P. Clancy, Michael P. Boyle, Jordan M. Dunitz
The New England Journal of Medicine. 2010-11-18
Press Mentions
- Keros Therapeutics Appoints Simon Cooper, M.B.B.S. As Chief Medical OfficerAugust 2nd, 2021
Grant Support
- Phase 2 Study Of VX-770 In Cystic Fibrosis Subjectswith G551DFood And Drug Administration2007
- Formula Forified W/ Docosahexaenoic Acid (DHA) In Infants W/ Cystic FibrosisNational Center For Research Resources2006
- Assessment Of Induced Sputum As A Tool To Evaluate Anti-Inflammatory AgentsNational Center For Research Resources2006
- P Aeruginosa Virulence In Cystic Fibrosis Lung DiseaseNational Heart, Lung, And Blood Institute2005–2006
- Use Of Sputum IND To Study Infection &Inflam In Child W/Cf PHS I&IiNational Center For Research Resources2005
- Tissue Bank For Pulmonary DiseasesNational Center For Research Resources2004–2005
- P. Aeruginosa Virulence In Cystic Fibrosis Lung DiseaseNational Heart, Lung, And Blood Institute2004
- Use Of Sputum Ind. To Study Infection &Inflam. In Child. W/C.F. PHS I&IiNational Center For Research Resources2004
- Study Of Airway Inflammation In Subjects With Cystic FibrosisNational Center For Research Resources2004
- Phase I Trial Comparing Two Delivery Methods And Doses Of Tobi In CF PatientsNational Center For Research Resources2004
- Cystic Fibrosis Once Daily Aminoglycoside Clinical Trial (CFODACT)National Center For Research Resources2004
- Free Elastase In BAL Fluid In Cystic Fibrosis PatientsNational Center For Research Resources2000–2002
- Airway Inflammation In Cystic FibrosisNational Center For Research Resources2000–2002
